Company registration number 11824275 (England and Wales)
PEST CONTROL SOLUTIONS LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
PAGES FOR FILING WITH REGISTRAR
PEST CONTROL SOLUTIONS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
PEST CONTROL SOLUTIONS LIMITED
BALANCE SHEET
AS AT 31 MARCH 2024
31 March 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Intangible assets
4
8,226
-
0
Tangible assets
5
27,111
-
0
35,337
-
0
Current assets
Stocks
49,555
38,339
Debtors
6
1,509
29,270
Cash at bank and in hand
161
4,040
51,225
71,649
Creditors: amounts falling due within one year
7
(122,048)
(115,533)
Net current liabilities
(70,823)
(43,884)
Net liabilities
(35,486)
(43,884)
Capital and reserves
Called up share capital
8
1
1
Profit and loss reserves
(35,487)
(43,885)
Total equity
(35,486)
(43,884)

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 16 October 2024
Mr J Kerman
Director
Company registration number 11824275 (England and Wales)
PEST CONTROL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024
- 2 -
1
Accounting policies
Company information

Pest Control Solutions Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Stables, Cranbrook Road, Hawkhurst, Cranbrook, TN18 4AU.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Research and development expenditure

Research and development expenditure is written off against profits in the year in which it is incurred.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Patents & licences
20 years straight line
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and equipment
15 years straight line
Computers
5 years straight line
1.5
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

PEST CONTROL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
1
Accounting policies
(Continued)
- 3 -
1.6
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

1.7
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in bank only.

1.8
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include other debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including other creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

1.9
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

1.11
Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.

PEST CONTROL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
4
Intangible fixed assets
Patents & licences
£
Cost
At 1 April 2023
-
0
Additions
8,226
At 31 March 2024
8,226
Amortisation and impairment
At 1 April 2023 and 31 March 2024
-
0
Carrying amount
At 31 March 2024
8,226
At 31 March 2023
-
0
PEST CONTROL SOLUTIONS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2024
- 5 -
5
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2023
-
0
Additions
28,759
At 31 March 2024
28,759
Depreciation and impairment
At 1 April 2023
-
0
Depreciation charged in the year
1,648
At 31 March 2024
1,648
Carrying amount
At 31 March 2024
27,111
At 31 March 2023
-
0
6
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
1,509
29,270
7
Creditors: amounts falling due within one year
2024
2023
£
£
Other creditors
122,048
115,533
8
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
1
1
1
1
9
Related party transactions

Included within other creditors is an amount of £121,298 (2023: £114,893) due to the company director. This loan is interest free and is repayable on demand,

2024-03-312023-04-01false16 October 2024CCH SoftwareCCH Accounts Production 2024.200No description of principal activityMr J Kermanfalsefalse118242752023-04-012024-03-31118242752024-03-31118242752023-03-3111824275core:PatentsTrademarksLicencesConcessionsSimilar2024-03-3111824275core:PatentsTrademarksLicencesConcessionsSimilar2023-03-3111824275core:OtherPropertyPlantEquipment2024-03-3111824275core:OtherPropertyPlantEquipment2023-03-3111824275core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3111824275core:CurrentFinancialInstrumentscore:WithinOneYear2023-03-3111824275core:ShareCapital2024-03-3111824275core:ShareCapital2023-03-3111824275core:RetainedEarningsAccumulatedLosses2024-03-3111824275core:RetainedEarningsAccumulatedLosses2023-03-3111824275bus:Director12023-04-012024-03-3111824275core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3111824275core:PatentsTrademarksLicencesConcessionsSimilar2023-04-012024-03-3111824275core:PlantMachinery2023-04-012024-03-3111824275core:ComputerEquipment2023-04-012024-03-31118242752022-04-012023-03-3111824275core:PatentsTrademarksLicencesConcessionsSimilar2023-03-3111824275core:PatentsTrademarksLicencesConcessionsSimilarcore:ExternallyAcquiredIntangibleAssets2023-04-012024-03-3111824275core:OtherPropertyPlantEquipment2023-03-3111824275core:OtherPropertyPlantEquipment2023-04-012024-03-3111824275core:WithinOneYear2024-03-3111824275core:WithinOneYear2023-03-3111824275core:CurrentFinancialInstruments2024-03-3111824275core:CurrentFinancialInstruments2023-03-3111824275bus:PrivateLimitedCompanyLtd2023-04-012024-03-3111824275bus:SmallCompaniesRegimeForAccounts2023-04-012024-03-3111824275bus:FRS1022023-04-012024-03-3111824275bus:AuditExemptWithAccountantsReport2023-04-012024-03-3111824275bus:FullAccounts2023-04-012024-03-31xbrli:purexbrli:sharesiso4217:GBP